129 related articles for article (PubMed ID: 9327946)
1. NGD 94-1: a specific dopamine-4-receptor antagonist.
Tallman JF
Adv Pharmacol; 1998; 42():490-2. PubMed ID: 9327946
[No Abstract] [Full Text] [Related]
2. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
Primus RJ; Thurkauf A; Xu J; Yevich E; McInerney S; Shaw K; Tallman JF; Gallagher DW
J Pharmacol Exp Ther; 1997 Aug; 282(2):1020-7. PubMed ID: 9262371
[TBL] [Abstract][Full Text] [Related]
3. I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor.
Tallman JF; Primus RJ; Brodbeck R; Cornfield L; Meade R; Woodruff K; Ross P; Thurkauf A; Gallager DW
J Pharmacol Exp Ther; 1997 Aug; 282(2):1011-9. PubMed ID: 9262370
[TBL] [Abstract][Full Text] [Related]
4. NGD 94-1 as an agonist at human recombinant dopamine D4.4 receptors expressed in HEK293 cells.
Gazi L; Sommer B; Nozulak J; Schoeffter P
Eur J Pharmacol; 1999 May; 372(3):R9-10. PubMed ID: 10395031
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.
Wilson JM; Sanyal S; Van Tol HH
Eur J Pharmacol; 1998 Jun; 351(3):273-86. PubMed ID: 9721018
[TBL] [Abstract][Full Text] [Related]
6. A selective dopamine D4 receptor antagonist, NRA0160: a preclinical neuropharmacological profile.
Okuyama S; Kawashima N; Chaki S; Yoshikawa R; Funakoshi T; Ogawa SI; Suzuki Y; Ikeda Y; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
Life Sci; 1999; 65(20):2109-25. PubMed ID: 10579464
[TBL] [Abstract][Full Text] [Related]
7. Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study.
Lahti RA; Roberts RC; Cochrane EV; Primus RJ; Gallager DW; Conley RR; Tamminga CA
Mol Psychiatry; 1998 Nov; 3(6):528-33. PubMed ID: 9857979
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor.
Liégeois JF; Bruhwyler J; Damas J; Rogister F; Masereel B; Geczy J; Delarge J
Eur J Pharmacol; 1995 Feb; 273(3):R1-3. PubMed ID: 7737323
[TBL] [Abstract][Full Text] [Related]
9. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
[TBL] [Abstract][Full Text] [Related]
10. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
Broderick PA; Piercey MF
J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
[TBL] [Abstract][Full Text] [Related]
11. Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition.
Mansbach RS; Brooks EW; Sanner MA; Zorn SH
Psychopharmacology (Berl); 1998 Jan; 135(2):194-200. PubMed ID: 9497025
[TBL] [Abstract][Full Text] [Related]
12. Dopamine inhibits melatonin synthesis in photoreceptor cells through a D2-like receptor subtype in the rat retina: biochemical and histochemical evidence.
Nguyen-Legros J; Chanut E; Versaux-Botteri C; Simon A; Trouvin JH
J Neurochem; 1996 Dec; 67(6):2514-20. PubMed ID: 8931485
[TBL] [Abstract][Full Text] [Related]
13. The D2 receptor: love it and leave it.
Pickar D
Mol Psychiatry; 1998 Mar; 3(2):101-2. PubMed ID: 9577830
[No Abstract] [Full Text] [Related]
14. Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications.
Lahti RA; Evans DL; Stratman NC; Figur LM
Eur J Pharmacol; 1993 Jun; 236(3):483-6. PubMed ID: 8102973
[TBL] [Abstract][Full Text] [Related]
15. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.
Seeman P; Corbett R; Van Tol HH
Neuropsychopharmacology; 1997 Feb; 16(2):93-110; discussion 111-35. PubMed ID: 9015795
[TBL] [Abstract][Full Text] [Related]
16. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045).
Okuyama S; Chaki S; Yoshikawa R; Suzuki Y; Ogawa S; Imagawa Y; Kawashima N; Ikeda Y; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
J Pharmacol Exp Ther; 1997 Jul; 282(1):56-63. PubMed ID: 9223539
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D4 receptors: curiouser and curiouser.
Strange PG
Trends Pharmacol Sci; 1994 Sep; 15(9):317-9. PubMed ID: 7992381
[No Abstract] [Full Text] [Related]
19. Prolonged treatment with haloperidol and clozapine in the rat: differential effects on spontaneous and theophylline-induced motor activity.
Ogren SO; Ferré S; Schwarcz R; Fuxe K
Neurosci Lett; 1997 Aug; 232(1):21-4. PubMed ID: 9292882
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.
Seeman P; Corbett R; Van Tol HH
Adv Pharmacol; 1998; 42():478-82. PubMed ID: 9327943
[No Abstract] [Full Text] [Related]
[Next] [New Search]
